Phase 1 study of KHK7580
Phase 1
- Conditions
- Secondary hyperparathyroidism in patients receiving peritoneal dialysis
- Registration Number
- JPRN-jRCT2080222486
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Written informed consent
- Stable chronic renal disease patients receiving peritoneal dialysis for at least 16 weeks prior to the screening
- intact PTH value >= 240 pg/mL at the screening
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method